Delivery Order SPE2DB24D2105-SPE2DB25FAPBV

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,152.19, is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of December 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract is a Firm Fixed Price Delivery Order valued at $1,838.56 with a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $11,017.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of December 20, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply the Defense Logistics Agency (DLA) Troop Support Medical with an AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract has a ceiling value of $1,203.28 and is a Delivery Order with a Firm Fixed Price pricing type. The contract has a period of performance through November 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a $2,707.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies to support military treatment facilities and other federal healthcare programs. The award is not associated with a set-aside program. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,434.50 Firm Fixed Price Delivery Order is for the supply of 4566188636 AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product. The contract has a ceiling value of $6,381.04 and an ultimate completion date of November 13, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, with a ceiling value of $23,758.61 and a completion date of December 17, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,086.62, is for the delivery of the medical product "AIRSUPRA 90-80 MCG INHALER 10.7GM" and has a period of performance through January 8, 2025. The contract was awarded as a Firm Fixed Price Delivery Order with no set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,844.87 firm fixed-price delivery order is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a respiratory medication. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB25FAPBV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,424.91, is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM medical devices. The contract is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 4/8/25, 9:59 AM